151 related articles for article (PubMed ID: 32940014)
1. Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.
Le-Rademacher J; Lopez C; Wolfe E; Foster NR; Mandrekar SJ; Wang X; Kumar R; Adjei A; Jatoi A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1501-1508. PubMed ID: 32940014
[TBL] [Abstract][Full Text] [Related]
2. Post-diagnosis weight loss as a prognostic factor in non-small cell lung cancer.
Mytelka DS; Li L; Benoit K
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):86-92. PubMed ID: 29205930
[TBL] [Abstract][Full Text] [Related]
3. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
Shukuya T; Takahashi K; Shintani Y; Miura K; Sekine I; Takayama K; Inoue A; Okamoto I; Kiura K; Kawaguchi T; Yamamoto N; Miyaoka E; Yoshino I; Date H
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1274-1285. PubMed ID: 36905129
[TBL] [Abstract][Full Text] [Related]
5. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
Lau SKM; Gannavarapu BS; Carter K; Gao A; Ahn C; Meyer JJ; Sher DJ; Jatoi A; Infante R; Iyengar P
J Oncol Pract; 2018 Apr; 14(4):e211-e220. PubMed ID: 29558251
[TBL] [Abstract][Full Text] [Related]
6. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
8. Validity of the diagnostic criteria from the Asian Working Group for Cachexia in advanced cancer.
Sakaguchi T; Maeda K; Takeuchi T; Mizuno A; Kato R; Ishida Y; Ueshima J; Shimizu A; Amano K; Mori N
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):370-379. PubMed ID: 38115133
[TBL] [Abstract][Full Text] [Related]
9. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
[TBL] [Abstract][Full Text] [Related]
10. Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.
Sanders KJ; Hendriks LE; Troost EG; Bootsma GP; Houben RM; Schols AM; Dingemans AM
J Thorac Oncol; 2016 Jun; 11(6):873-9. PubMed ID: 26940529
[TBL] [Abstract][Full Text] [Related]
11. Relationship between efficacy outcomes and weight gain during treatment of advanced, non-squamous, non-small-cell lung cancer patients.
Patel JD; Pereira JR; Chen J; Liu J; Guba SC; John WJ; Orlando M; Scagliotti G; Bonomi PD
Ann Oncol; 2016 Aug; 27(8):1612-9. PubMed ID: 27217544
[TBL] [Abstract][Full Text] [Related]
12. The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival.
Turcott JG; Martinez-Samano JE; Cardona AF; Bassarmal SS; Ramírez-Tirado LA; Zatarain-Barrón ZL; Barrón F; Corrales L; Martín C; Barragán-Castillo PA; Ruiz-Patiño A; Flores-Estrada D; Arrieta O
Nutr Cancer; 2021; 73(5):794-801. PubMed ID: 32482104
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study.
Kwan HY; Maddocks M; Nolan CM; Jones SE; Patel S; Barker RE; Kon SSC; Polkey MI; Cullinan P; Man WD
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1330-1338. PubMed ID: 31207189
[TBL] [Abstract][Full Text] [Related]
14. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
Martin L; Birdsell L; Macdonald N; Reiman T; Clandinin MT; McCargar LJ; Murphy R; Ghosh S; Sawyer MB; Baracos VE
J Clin Oncol; 2013 Apr; 31(12):1539-47. PubMed ID: 23530101
[TBL] [Abstract][Full Text] [Related]
15. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
[TBL] [Abstract][Full Text] [Related]
16. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
Vagnildhaug OM; Blum D; Wilcock A; Fayers P; Strasser F; Baracos VE; Hjermstad MJ; Kaasa S; Laird B; Solheim TS;
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):789-797. PubMed ID: 28627024
[TBL] [Abstract][Full Text] [Related]
17. An analysis of the relationship between metastases and cachexia in lung cancer patients.
Shiono M; Huang K; Downey RJ; Consul N; Villanueva N; Beck K; Fenn K; Dietz D; Yamaguchi T; Kato S; Divgi C; Kalinsky K; Wei Y; Zhang Y; Borczuk AC; Inoue A; Halmos B; Acharyya S
Cancer Med; 2016 Sep; 5(9):2641-8. PubMed ID: 27485414
[TBL] [Abstract][Full Text] [Related]
18. Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors.
Roch B; Coffy A; Jean-Baptiste S; Palaysi E; Daures JP; Pujol JL; Bommart S
Lung Cancer; 2020 May; 143():19-26. PubMed ID: 32200137
[TBL] [Abstract][Full Text] [Related]
19. Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients.
Jouinot A; Ulmann G; Vazeille C; Durand JP; Boudou-Rouquette P; Arrondeau J; Tlemsani C; Fournel L; Alifano M; Wislez M; Chapron J; Le Bris C; Mansuet-Lupo A; Damotte D; Neveux N; De Bandt JP; Alexandre J; Cynober L; Goldwasser F
Clin Nutr; 2020 Jun; 39(6):1893-1899. PubMed ID: 31443979
[TBL] [Abstract][Full Text] [Related]
20. Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patients.
Namikawa T; Marui A; Yokota K; Fujieda Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
Surg Today; 2022 Nov; 52(11):1560-1567. PubMed ID: 35322296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
